A meta-analysis of randomized trials of calcium antagonists to reduce restenosis after coronary angioplasty
Authors:
- E.Magnus OhmanEOE.Magnus Ohman
- Jeffrey D. LeimbergerJLJeffrey D. Leimberger
- Robert M. CaliffRCRobert M. Califf
- 1 May 1994
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 73 (12) , 835-839
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Calcium antagonists differently inhibit proliferation of human coronary smooth muscle cells in response to pulsatile stretch and platelet-derived growth factor.Circulation, 1993
- Restenosis after coronary angioplasty: An overviewJACC, 1991
- Prevention of Restenosis After PTCAJournal of Cardiovascular Pharmacology, 1991
- Comparison of diltiazem and nifedipine alone and in combination in patients with coronary artery spasmJACC, 1987
- Antiatherogenic properties of calcium antagonistsThe American Journal of Cardiology, 1987
- Effect of nifedipine on recurrent stenosis after percutaneous transluminal coronary angioplastyJACC, 1986
- Atherosclerosis, calcium, and calcium antagonists.Circulation, 1985
- Failure of diltiazem to prevent restenosis after percutaneous transluminal coronary angioplastyAmerican Heart Journal, 1985
- Modification of experimental atherosclerosis by calcium-channel blockersThe American Journal of Cardiology, 1985
- Suppression of experimental atherosclerosis by the Ca++-antagonist lanthanum. Possible role of calcium in atherogenesis.Journal of Clinical Investigation, 1980